Natural antibiotic susceptibility of Enterobacter spp., with special reference to Enterobacter aerogenes and Enterobacter intermedius strains

Journal of Chemotherapy

Volumn 14, Issue 5, 2002, Pages 444-460

  Stock, Ingo ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

AmpC lactamase; E. amnigenus; E. asburiae; E. cancerogenus; E. cloacae sensu stricto; E. gergoviae; E. hormaechei; E. intermedius; E. sakazakii; Enterobacter aerogenes; Fosfomycin; Natural antibiotic susceptibility; Natural resistance; Natural sensitivity

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; KANAMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; MINOCYCLINE; NETILMICIN; NITROFURANTOIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE; STREPTOMYCIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER INTERMEDIUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0036810683     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.5.444     Document Type: Article

References (46)

1. Mallea M, Chevalier J, Bornet C, et al. Porin alteration and active efflux: Two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 1998; 144: 3003-9.
2. Mardrus P, Le Grand JL, Chardon H, Garrigues B. [Enterobacter aerogenes pneumopathy treated by a cefepime-subactam-gentamicin combination.] Presse Med 1998; 27: 804-5.
3. Bornet C, Davin-Regli A, Bosi C, Pages JM, Bollet C. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol 2000; 38: 1048-52.
4. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-specrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000; 38: 542-6.
5. Brenner DJ, Steigerwalt AG, Fanning GR. Differentiation of Enterobacter aerogenes from klebsiellae by deoxyribonucleic acid reassociation. Int J Syst Bacteriol 1972; 22: 193-200.
6. Steigerwalt AG, Fanning GR, Fife-Asbury MA, Brenner DJ. DNA relatedness among species of Enterobacter and Serratia. Can J Microbiol 1976; 22: 121-37.
7. Brenner DJ. Introduction to the family Enterobacteriaceae. In: Balows A, Trüper HG, Dworkin M, Harder W, Schleifer KH, editors. The Prokaryotes: A Handbook on the Biology of Bacteria: Ecophysiology, Isolation, Identification, Applications, vol. III. New York: Springer, 1992: 2673-95.
8. Bacomb S, Lapage SP, Curtis MA, Willcox WR. Numerical classification of the tribe Klebsiellae. J Gen Microbiol 1971; 66: 279-95.
9. Izard D, Gavini F, Leclerc H. Polynucleotide sequence relatedness and genome size among Enterobacter intermedium sp. nov. and the species Enterobacter cloacae and Klebsiella pneumoniae. Zentralbl Bakteriol 1980 (1 Abt, Originale C1): 51-60.
10. AL. In: Krieg NR, Holt JG (editors), Bergey's Manual of Systematic Bacteriology, Vol. 1. Baltimore: Williams and Wilkins, 1885: 461-5.
11. Grimont F, Grimont PAD. The genus Enterobacter. In: Balows A, Trüper HG, Dworkin M, Harder W, Schleifer KH, editors. The Prokaryotes: A Handbook on the Biology of Bacteria: Ecophysio-logy, Isolation, Identification, Applications, vol. III. New York: Springer, 1992: 2797-815.
12. 1) apparanté à l'espèce Enterobacter cloacae. Can J Microbiol 1979; 25: 713-18.
13. Lapage SP, Sneath PHA, Lessel EF, Skerman VBD, Seeliger HPR, Clark WA (ed). International Code of Nomenclature of Bacteria. Revision. American Society for Microbiology, Washington, DC. 1975.
14. von Graevenitz A. Revised nomenclature of Campylobacter laridis, Enterobacter intermedium, and Flavobacterium branchiophila. Int J Syst Bacteriol 1990; 40: 211.
15. Prats G, Richard C, Mirelis B, Lopez P. Human isolates of Enterobacter intermedius. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene (Serie A) 1987; 266: 422-4.
16. Janicka G, Kania I, Ulatowska B, Kruszynska E, Wojda M. The occurrence of the Enterobacter genus rods in the clinical materials and materials taken from hospital environment. (Article in Polish) Wiad Lek 1999; 52: 554-8.
17. O'Hara CM, Steward CD, Wright JL, Tenover FC, Miller JM. Isolation of Enterobacter intermedius from the gallbladder of a patient with cholecystitis. J Clin Microbiol 1998; 36: 3055-6.
18. Stock I, Grüger T, Wiedemann B. Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int J Antimicrob Agents 2001; 18: 537-45.
19. Stock I, Wiedemann B. Natural antibiotic susceptibility of Enterobacter amnigenus, E. cancerogenus, E. gergoviae and E. sakazakii strains. Clin Microbiol Infect 2002, in press.
20. Inoue K, Sugiyama K, Kosako Y, Sakazaki R. Yamai S. Enterobacter cowanii sp. nov., a new species of the family Enterobacteriaceae. Curr Microbiol 2000; 41: 417-20.
21. Kosako Y, Tamura K, Sakazaki R, Miki K. Enterobacter kobei sp. nov., a new species of the family Enterobacteriaceae resembling Enterobacter cloacae. Curr Microbiol 2000; 33: 261-5.
22. Stock I, Wiedemann B. Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. J Med Microbiol 1998; 47: 629-42.
23. Stock I, Wiedemann B. An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database. J Antimicrob Chemother 1999; 43: 37-45.
24. Stock I, Wiedemann B. Natural β-lactam susceptibility and mechanisms of β-lactam resistance in Yersinia enterocolitica. Rev Med Microbiol 2000; 11: 197-210.
25. Deutsches Institut für Normung e.V. DIN document 58940-4, Table 1. Susceptibility Testing of Pathogens to Antimicrobial Agents, Part 4: Evaluation Classes of the Minimum Inhibitory Concentration, Supplement 1: MIC Breakpoints of Antibacterial Agents. Deutsches Institut für Normung e.V., Berlin, Germany2000.
26. Comité de l'Antibiogramme de la Société Française de Microbiologie Communiqué. Statement. Pathol Biol 1998; 46: I-XVI.
27. Olsson-Liljequist B, Larson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. Part 3: Methology for susceptibility testing. Scand J Infect Dis 1997; 105 (Suppl): 13-23.
28. National Committee for Clinical Laboratory Standards. NCCLS document M7-A5, Table 2A. Minimum Inhibitory Concentration (MIC) Interpretive Standards (μg/ml) for Enterobacteriaceae. Villanova, Pa. National Committee for Clinical Laboratory Standards. 2000.
29. National Committee for Clinical Laboratory Standards. NCCLS document M7-A5, Table 2F. Minimum Inhibitory Concentration (MIC) Interpretive Standards (μg/ml) for Neisseria gonorrhoe. Villanova, Pa, National Committee for Clinical Laboratory Standards. 2000.
30. National Committee for Clinical Laboratory Standards. NCCLS document M7-A5, Table 2C. Minimum Inhibitory Concentration (MIC) Interpretive Standards (μg/ml) for Staphylococcus spp. Villanova, Pa. National Committee for Clinical Laboratory Standards. 2000.
31. Troxler R, von Graevenitz A, Funke G, Wiedemann B, Stock I. Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seel-igeri and L. welshimeri strains. Clin Microbiol Infect 2000; 6: 525-35.
32. Nikaido H. Outer membrane. In Neinhardt FC, editor. Escherichia coli and Salmonella Typhimurium, Cellular and Molecular Biology. Washington DC, American Society for Microbiology. 1996: 29-47.
33. Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in Gram-negative enteric bacteria. Antimicrob Agents Chemother 1993; 37: 354-6.
34. O'Hara K. Two different types of fosfomycin resistance in clinical isolates of Klebisella pneumoniae. FEMS Microbiol Lett 1993; 114: 9-16.
35. Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
36. Hennessey TD: Inducible β-lactamase in Enterobacter. J Gen Microbiol 1967; 49: 277-85.
37. Pitout JD, Moland ES, Sanders CC, Thomson KS, Fitzsimmons SR. β-lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother 1997; 41: 35-9.
38. Preston KE, Radomski CC, Veenzia RA. Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes. Antimicrob Agents Chemother 2000; 44: 3158-62.
39. Galleni M, Lindberg F, Normark S, Cole S, Honoré N, Joris B, Frere J. Sequence and comparative analysis of three Enterobacter cloacae ampC β-lactamase genes and their products. Biochem J 1988; 250: 753-60.
40. Lindberg F, Normark S. Sequence of the Citrobacter freundii OS60 chromosomal ampC β-lactamase gene. Eur J Biochem 1986; 156: 441-5.
41. Stock I, Wiedemann B. Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains. J Med Microbiol 2001; 50: 396-406.
42. Brenner DJ, McWhorther AC, Kai A, Steigerwalt AG, Farmer JJ III. Enterobacter asburiae sp. nov., a new species found in clinical specimens, and reassignment of Erwinia dissolvens and Erwinia nimipressuralis to the genus Enterobacter as Enterobacter dissolvens comb. nov. and Enterobacter nimipressuralis comb. nov. J Clin Microbiol 1986; 23: 1114-20.
43. O'Hara CM, Steigerwalt AG, Hill BC, Farmer JJ III, Fanning GR, Brenner DJ. Enterobacter hormaechei, a new species of the family Enterobacteriaceae formerly known as Enteric group 75. J Clin Microbiol 1989; 27: 2046-9.
44. Muytjens HL, van de Ros-van de Repe J. Comparative in vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii. Antimicrob Agents Chemother 1986; 29: 367-70.
45. Normark S, Grundstrom T, Bergstrom S. Susceptibility to penicillins and cephalosporins in β-lactamase producing strains of Escherichia coli and relative amount of β-lactamase produced by these strains. Scand J Infect Dis 1980; 25: 23-9.
46. Stock I, Wiedemann B. Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri and E. hoshinae. Antimicrob Agents Chemother 2001; 45: 2245-55.